Table 2. Monoclonal expansions dominate the islet-infiltrating CD4+CD44high T cell repertoire at diabetes onset1.
Mouse2 | TRBV gene | TRBJ gene | CDR3 sequence3 | CDR3 Length4 | Frequency5 |
8 | 15 | 2-1 | SPGAEQFF | 27 | 41.4 |
1 | 1-1 | SADNRVDTEVFF | 39 | 17.1 | |
10 | 19 | 1-3 | STGTARSGNLYF | 42 | 68.7 |
1 | 2-5 | SAGGQGLDTQYF | 39 | 22.0 | |
11 | 1 | 2-2 | SASGQNTGQLYF | 39 | 34.8 |
13-3 | 1-2 | SDPGGSDYTF | 33 | 22.6 | |
12 | 1 | 1-1 | SAAQNTEVFF | 33 | 53.7 |
16 | 2-5 | SFRDRKDTQYF | 36 | 26.0 | |
14 | 19 | 2-5 | SAGTGGRQDTQYF | 42 | 22.9 |
19 | 2-5 | RPWGNQDTQYF | 36 | 15.9 | |
15 | 13-3 | 1-6 | SDRGTNSLYF | 36 | 41.5 |
16 | 16 | 2-1 | SLVGGNYAEQFF | 39 | 35.6 |
17 | 2-5 | SREGVNQDTQYF | 39 | 24.3 | |
19 | 2-2 | SIWGGNTGQLYF | 39 | 16.5 |
Monoclonal expansions are defined as clonotypes representing >15% of total CDR3β sequences.
Numbers correspond to the diabetic mice identified in Table 1. Only the seven mice having monoclonal expansions are shown.
Amino acid sequences between the conserved cysteine and phenylalanine residues, as defined by IMGT [57].
CDR3 length of nucleotides.
Raw frequency of each clonotype within the total CDR3β sequences obtained from each mouse.